mci 9038 has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G | 1 |
| Hoff, JT; Hua, Y; Keep, RF; Schallert, T; Xi, G | 1 |
| Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, LL; Xi, GH | 1 |
3 other study(ies) available for mci 9038 and Brain Neoplasms
| Article | Year |
|---|---|
Thrombin enhances glioma growth.
Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2008 |
A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model.
Topics: Animals; Antithrombins; Arginine; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Glioma; Immunohistochemistry; Nervous System Diseases; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Thrombin | 2003 |
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Topics: Animals; Anticoagulants; Antineoplastic Agents; Arginine; Brain; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Injections, Intraventricular; Male; Mental Disorders; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Treatment Outcome | 2005 |